Bimatoprost
Bimatoprost. Prostamide F2α analog — same uveoscleral-outflow mechanism as latanoprost; topical formulation also FDA-approved for… Transdermal half-life 1 h.
Prostamide F2α analog — same uveoscleral-outflow mechanism as latanoprost; topical formulation also FDA-approved for hypotrichosis (eyelash growth) as Latisse. Iris pigmentation change + periocular skin darkening.